Vanda Pharmaceuticals, Inc. (VNDA)
4.63
-0.18
(-3.74%)
USD |
NASDAQ |
Oct 02, 16:00
4.625
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Market Cap : 279.91M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 279.91M |
| October 01, 2026 | 290.79M |
| September 30, 2026 | 296.83M |
| September 29, 2026 | 304.09M |
| September 28, 2026 | 312.55M |
| September 25, 2026 | 305.30M |
| September 24, 2026 | 301.06M |
| September 23, 2026 | 304.69M |
| September 22, 2026 | 314.97M |
| September 21, 2026 | 311.64M |
| September 18, 2026 | 310.13M |
| September 17, 2026 | 308.92M |
| September 16, 2026 | 302.27M |
| September 15, 2026 | 301.67M |
| September 14, 2026 | 311.34M |
| September 11, 2026 | 307.71M |
| September 10, 2026 | 304.69M |
| September 09, 2026 | 317.39M |
| September 08, 2026 | 322.22M |
| September 04, 2026 | 328.27M |
| September 03, 2026 | 322.83M |
| September 02, 2026 | 334.31M |
| September 01, 2026 | 327.66M |
| August 31, 2026 | 326.46M |
| August 28, 2026 | 319.81M |
| Date | Value |
|---|---|
| August 27, 2026 | 328.87M |
| August 26, 2026 | 323.43M |
| August 25, 2026 | 328.87M |
| August 24, 2026 | 322.22M |
| August 21, 2026 | 319.20M |
| August 20, 2026 | 325.25M |
| August 19, 2026 | 336.73M |
| August 18, 2026 | 328.87M |
| August 17, 2026 | 317.99M |
| August 14, 2026 | 315.57M |
| August 13, 2026 | 304.09M |
| August 12, 2026 | 313.76M |
| August 11, 2026 | 298.04M |
| August 10, 2026 | 303.48M |
| August 07, 2026 | 302.27M |
| August 06, 2026 | 309.23M |
| August 05, 2026 | 307.71M |
| August 04, 2026 | 322.22M |
| August 03, 2026 | 314.51M |
| July 31, 2026 | 306.69M |
| July 30, 2026 | 311.50M |
| July 29, 2026 | 303.68M |
| July 28, 2026 | 310.30M |
| July 27, 2026 | 313.91M |
| July 24, 2026 | 311.50M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| SELLAS Life Sciences Group, Inc. | 2.371B |
| Protagonist Therapeutics, Inc. | 9.058B |
| Sagimet Biosciences, Inc. | 564.70M |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
Market Cap Related Metrics
| PS Ratio | 1.276 |
| PEG Ratio | -0.0033 |
| Price to Book Value | 1.271 |
| Price | 4.63 |
| Earnings Yield | -99.91% |
| PEGY Ratio | -0.0033 |